Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Haemato AG Earnings Release 2013

Apr 14, 2014

5404_rns_2014-04-14_afd7cfd3-be7f-4592-a230-44f7ce11e22a.html

Earnings Release

Open in viewer

Opens in your device viewer

News Details

Corporate | 14 April 2014 10:34

HAEMATO AG: 2013: Final IFRS results, sales of EUR 173.57 million, annual net income of EUR 8.38 million; proposal on the increase in the dividend from EUR 0.25 to EUR 0.30 per share

HAEMATO AG / Key word(s): Final Results/Dividend

14.04.2014 / 10:34


2013: Final IFRS results, sales of EUR 173.57 million, annual net income of EUR 8.38 million; proposal on the increase in the dividend from EUR 0.25 to EUR 0.30 per share

In the financial year 2013 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS Group sales of EUR 173.57 m (previous year: EUR 25.04 m) and profit of EUR 8.38 m (previous year: EUR 7.41 m; thereof non-recurring profit from sales of property of EUR 7.26 m).

“HAEMATO AG has the potential for further growth of the pharmaceuticals business, which is characterized by stable cash flows. The management proposes an increase in the dividend from EUR 0.25 to EUR 0.30 per share for approval by the Annual General Meeting on May, 28, 2014”, says Dr. Christian Pahl, Member of the Management Board of HAEMATO AG.

About HAEMATO:

HAEMATO AG was founded in 1993 and is a stock exchange quoted pharmaceutical company. The company is listed on the Frankfurt Stock Exchange in the Entry Standard (Open Market) and is based in Schönefeld, Germany.

The focus of the business activities lies on the growth markets of patent free and patent protected medicinal products. Focal points are therapies for cancer, HIV, cardiovascular and other chronic diseases.

Contact:

HAEMATO AG, Investor Relations

Telefon: +49 (0)30 897 30 86 70

[email protected]

End of Corporate News


14.04.2014 Dissemination of a Corporate News, transmitted by DGAP – a company of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


263048  14.04.2014